ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Albertus M. Scheule
Wulf Dietrich
Gerhard Ziemer
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beierlein, W.
Right arrow Articles by Ziemer, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beierlein, W.
Right arrow Articles by Ziemer, G.
Related Collections
Right arrow Cardiac - pharmacology

Ann Thorac Surg 2005;79:741-748
© 2005 The Society of Thoracic Surgeons

Review

Forty Years of Clinical Aprotinin Use: A Review of 124 Hypersensitivity Reactions

Wolfram Beierlein, MDa,*, Albertus M. Scheule, MD, PhDa, Wulf Dietrich, MD, PhDb, Gerhard Ziemer, MD, PhDa

a Department of Thoracic, Cardiac, and Vascular Surgery, Tübingen University Hospital, Tübingen, Germany
b Department of Anesthesiology, German Heart Center Munich, Munich, Germany

* Address reprint requests to Dr Beierlein, Department of Thoracic, Cardiac and Vascular Surgery, Tübingen University Hospital, Hoppe-Seyler Straße 3, D-72076 Tübingen, Germany
wolfram.beierlein{at}t-online.de

Since its clinical introduction, the anaphylactic potential of aprotinin has been a major concern. World wide, its use is expanding so there is an increased chance that patients have reexposure from various sources. The risk of anaphylaxis is approximately 2.8% in reexposed patients. From 1963 to 2003, 124 cases of aprotinin-induced anaphylaxis were reported in 61 publications. Eleven patients died. The reexposure interval was less than 3 months in 72% (38 of 53 patients). This review looks at the profile of patients at risk so preventive measures may be taken. Past and future exposures have to be taken into account before any aprotinin administration.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
B. J. Kober, A. M. Scheule, V. Voth, N. Deschner, E. Schmid, and G. Ziemer
Anaphylactic Reaction After Systemic Application of Aprotinin Triggered by Aprotinin-Containing Fibrin Sealant
Anesth. Analg., August 1, 2008; 107(2): 406 - 409.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
C. Schummer, M. Wirsing, and W. Schummer
The Pivotal Role of Vasopressin in Refractory Anaphylactic Shock
Anesth. Analg., August 1, 2008; 107(2): 620 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. P. Eaton
Antifibrinolytic Therapy in Surgery for Congenital Heart Disease
Anesth. Analg., April 1, 2008; 106(4): 1087 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
W. I. Schievink, S. A. Georganos, M. M. Maya, F. G. Moser, and M. Bladyka
ANAPHYLACTIC REACTIONS TO FIBRIN SEALANT INJECTION FOR SPONTANEOUS SPINAL CSF LEAKS
Neurology, March 11, 2008; 70(11): 885 - 887.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. H. Levy and N. F. Adkinson Jr
Anaphylaxis During Cardiac Surgery: Implications for Clinicians
Anesth. Analg., February 1, 2008; 106(2): 392 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. Dietrich, A. Ebell, R. Busley, and A.-L. Boulesteix
Aprotinin and Anaphylaxis: Analysis of 12,403 Exposures to Aprotinin in Cardiac Surgery
Ann. Thorac. Surg., October 1, 2007; 84(4): 1144 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Veres, T. Radovits, H. Schultz, L.-n. Lin, J. Hutter, E. Weigang, Z. Szabolcs, and G. Szabo
Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 340 - 345.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. G.T. Augoustides
Limitations with aprotinin in thoracic aortic surgery: Understanding the clinical outcome beyond bleeding
J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 269 - 269.
[Full Text] [PDF]

Home page
 CirculationHome page
C. R. Bridges
Valid Comparisons of Antifibrinolytic Agents Used in Cardiac Surgery
Circulation, June 5, 2007; 115(22): 2790 - 2792.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
L. F. L. Almodovar, P. Lima, A. Canas, and M. Calleja
Fatal anaphylactoid reaction after primary exposure to aprotinin
Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 25 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. Shiga, Z. Wajima, T. Inoue, and A. Sakamoto
Aprotinin in Major Orthopedic Surgery: A Systematic Review of Randomized Controlled Trials
Anesth. Analg., December 1, 2005; 101(6): 1602 - 1607.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.